doctor, what does this is a about the fda s ability to police these products and protect the public? well, i think that we have a repeat of what happened with vioxx back in 2004. with that drug, fda preferred to represent the interest of industry rather than protecting patients from harm and allowed vioxx to remain on the market. long after we knew that increased heart attack prinks with avandia it was clear in 2007, avandia increased heart attack rinks. you raised questions about the company s own report on this drug, correct? you that s correct. you said it wasn t credible. well, that s true. and the studies that they presented, i think the committee concluded weren t credible either. the problem is that fda approved this drug. the people who approved avandia are the people who are deciding whether or not avandia should remain on the market. and it was the same people who approved vioxx and who left vioxx on the market.